Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study)
-
Published:2023-07-06
Issue:9
Volume:14
Page:1517-1535
-
ISSN:1869-6953
-
Container-title:Diabetes Therapy
-
language:en
-
Short-container-title:Diabetes Ther
Author:
Sugawara MasahiroORCID, Fukuda Masahiro, Sakuma Ichiro, Wakasa Yutaka, Funayama Hideaki, Kondo Akira, Itabashi Naoki, Maruyama Yasuyuki, Kamiyama Takashi, Utsunomiya Yasunori, Yamauchi Akira, Yoshii Hidenori, Yamada Hirokazu, Mochizuki Koichi, Seino Hiroaki, Murata Kaori, Yatagai Shigeo, Koyama Hiroshi, Yamamoto Hareaki, Shimizu Miho, Kawada Toshio, Sakagashira Setsuya, Ozeki Shigehiko, Takeda Tomoo, Katsuya Tomohiro, Oishi Mariko, Doniwa Ken-ich, Ueda Nobuyuki, Sasamoto Makiko, Masaki Hatsumi, Kamiyama Takashi, Lee Woon-Joo, Chimori Hiroko, Takeda Hiroshi, Ikeda Kazuo, Nishioka Hiroaki, Mitsuhashi Kyoko, Kinugawa Toru, Miki Motoko, Horiuchi Toshiyuki, Doi Kunihiro, Shinagawa Yuki, Shimozono Isato, Ishizuka Jinro, Sakurai Shunichiro, Moritani Shigeki, Kase Norio, Watanabe Shigeru, Nakata Shinsuke, Tsunoda Keiko, Sawanishi Tadashi, Ogawa Yuji, Matsuda Tomokazu, Tsuji Tomohiro, Shirabe Shinichiro, Ashitomi Satoshi, Ogata Hiromi, Matsuo Kaneyuki, Sugie Takashi, Takenaka Ken, Tanaka Asami, Suzuki Yoshiro, Inoue Masahiro, Hasegawa Hiroshi, Nakao Haruyoshi, Nishikawa Tetsuo, Uematsu Mikio, Uchida Daigaku, Miyakawa Masaaki, Takihata Masahiro, Ishii Hirotaka, Mizuno Kenji, Inomata Masahiko, Minamisawa Kosuke, Honda Soichi, Shirakawa Mitsuo, Fuse Katsuya, Yamao Takuji, Nakazima Akihiko, Nagano Masahiro, Nakamura Masahiko, Iwami Suzuko, Degawa Hisakazu, Katayanagi Naoko, Okada Yoshiharu, Sawaki Hideaki, Ogata Hiromi, Miyano Motoshige, Matsuda Yuki,
Funder
Taisho Pharmaceutical Co., Ltd.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Reference40 articles.
1. Demir S, Nawroth PP, Herzig S, Ekim ÜB. Emerging targets in type 2 diabetes and diabetic complications. Adv Sci (Weinh). 2021;8: e2100275. 2. Aung K, Lorenzo C, Hinojosa MA, Haffner SM. Risk of developing diabetes and cardiovascular disease in metabolically unhealthy normal-weight and metabolically healthy obese individuals. J Clin Endocrinol Metab. 2014;99:462–8. 3. Zhou K, Donnelly LA, Morris AD, et al. Clinical and genetic determinants of progression of type 2 diabetes: a DIRECT study. Diabetes Care. 2014;37:718–24. 4. Muramoto A, Matsushita M, Kato A, et al. Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan. Obes Res Clin Pract. 2014;8:e466-475. 5. The Welfare Science Council in the Ministry of Health, Labour and Welfare in Japan. Reference material on the promotion of Healthy Japan 21 (Second). 2012. https://www.mhlw.go.jp/bunya/kenkou/dl/kenkounippon21_02.pdf. Accessed 4 Feb 2019.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|